Cutter & Co Brokerage’s TIANYIN PHARMACEUTICAL TPI Stock Holding History

Cutter & Co Brokerage’s Portfolio TPI Stock Details TPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-69,500	Closed	-$52K	–	229
2013 Q3	$52K	Sell	69,500 -4,900	-7%	-$3.23K	0.02%	218
2013 Q2	$36K	Buy	+74,400	New	+$43.8K	0.02%	206

Other funds holding TPI

Pope Asset Management Memphis, Tennessee $162M AUM

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return

Regent Investment Management Louisville, Kentucky $373M AUM 10.22% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Baltimore-Washington Financial Advisors Columbia, Maryland $2.32B AUM 16.8% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Cutter & Co Brokerage's TPI Position: Q4 2013 in Review

Cutter & Co Brokerage sold out of TIANYIN PHARMACEUTICAL (TPI) in Q4 2013, closing a stake of 69,500 shares — an estimated $52K sold.

Cutter & Co Brokerage first reported a position in TPI in Q2 2013 and held it in 2 quarters. The position peaked at $52K in Q3 2013. 8 funds tracked by Wall St. Rank hold TPI as of Q4 2013.

Cutter & Co Brokerage reported no remaining TIANYIN PHARMACEUTICAL position as of Q4 2013 after selling out during the quarter.
Cutter & Co Brokerage sold 69,500 TIANYIN PHARMACEUTICAL shares in Q4 2013, an estimated $52K.
Cutter & Co Brokerage first reported a position in TIANYIN PHARMACEUTICAL in Q2 2013 and held it in 2 quarters.
Cutter & Co Brokerage's TIANYIN PHARMACEUTICAL position peaked at $52K in Q3 2013.
8 funds tracked by Wall St. Rank held TIANYIN PHARMACEUTICAL as of Q4 2013.

Based on Cutter & Co Brokerage's 13F filing for Q4 2013, filed 4 Feb 2014.